A late-stage trial testing the combination of Gilead Sciences' remdesivir and a highly concentrated solution of antibodies that neutralize the COVID-19 virus has begun, the National Institutes of ...
Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in ...
WOODLAND HILLS, LOS ANGELES (KABC) -- Cory Palka is an LAPD commander who tested positive for COVID-19 in March. He's since recovered and is trying to help others by donating plasma. Palka visited the ...
CHICAGO (WLS) -- Caitlin Darcy is a server at Beatnik in West Town. She lost her job when the state shuttered all bars and restaurants. Then she contracted COVID-19. After four days of severe aches, ...
HOUSTON, Texas (KTRK) -- A possible breakthrough in treating COVID-19 is not getting the fast approval initially thought. Last week, the Food and Drug Administration was getting ready to issue an ...
With emergency permission for using plasma donated by recovered COVID-19 patients to treat sick ones, some researchers are once again raising concerns that the push for speed is getting ahead of the ...
A National Institutes of Health panel released a statement on Tuesday saying that convalescent plasma should “ not be considered standard of care for the treatment of patients with COVID-19.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback